• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过使用一种 morpholino 寡核苷酸阻断外显子 4 的 5' 剪接位点可引发 APOL1 蛋白异构体转换。

Blocking the 5' splice site of exon 4 by a morpholino oligomer triggers APOL1 protein isoform switch.

机构信息

Meharry Medical College, Center for AIDS Health Disparities Research, Department of Microbiology and Immunology, 1005 D. B. Todd Blvd, Nashville, TN, 37028, USA.

Department of Internal Medicine, 1005 D. B. Todd Blvd, Nashville, TN, 37028, USA.

出版信息

Sci Rep. 2018 Jun 7;8(1):8739. doi: 10.1038/s41598-018-27104-x.

DOI:10.1038/s41598-018-27104-x
PMID:29880816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5992166/
Abstract

APOL1 risk alleles G1 or G2 are associated with a kidney disease phenotype exclusively in people of recent African ancestry. Here we show that exon 4 encoding a part of the APOL1 signal peptide is constitutively spliced in major APOL1 transcripts expressed in kidney glomerular and tubular cells. We demonstrate that constitutive splicing of exon 4 results from a suboptimal hnRNP A1 binding motif found in exon 4. Accordingly, a robust binding of hnRNP A1 protein to a consensus hnRNP A1 cis-acting element in exon 4 results in almost complete exclusion of exon 4 from the APOL1 minigene transcripts. Blocking the 5' splice site at the exon 4/intron boundary with a specific antisense morpholino oligonucleotide excludes exon 4 from the splicing pattern of endogenous APOL1 transcripts. These transcripts are fully functional and produce APOL1 protein isoform that is not normally detectable in podocytes. Together with our previous data showing no cytotoxicity of overexpressed APOL1 isoform lacking exon 4, we propose that morpholino-induced APOL1 isoform switch may provide a new tool to identify in vivo molecular mechanism(s) by which risk alleles promote or mediate the kidney disease phenotype.

摘要

APOL1 风险等位基因 G1 或 G2 仅与最近具有非洲血统人群的肾脏疾病表型相关。在这里,我们表明编码 APOL1 信号肽一部分的外显子 4 在肾脏肾小球和肾小管细胞中表达的主要 APOL1 转录物中是组成性剪接的。我们证明,外显子 4 的组成性剪接是由于在外显子 4 中发现了一个不合适的 hnRNP A1 结合基序。因此,hnRNP A1 蛋白与外显子 4 中的一致 hnRNP A1 顺式作用元件的强烈结合导致外显子 4 几乎完全从 APOL1 迷你基因转录物中排除。用特异性反义 morpholino 寡核苷酸阻断外显子 4/内含子边界的 5'剪接位点可将外显子 4 从内源性 APOL1 转录物的剪接模式中排除。这些转录物是完全功能性的,并产生通常在足细胞中不可检测到的 APOL1 蛋白同工型。结合我们之前的数据显示缺乏外显子 4 的过表达 APOL1 同工型没有细胞毒性,我们提出,morpholino 诱导的 APOL1 同工型转换可能为鉴定风险等位基因促进或介导肾脏疾病表型的体内分子机制提供新工具。

相似文献

1
Blocking the 5' splice site of exon 4 by a morpholino oligomer triggers APOL1 protein isoform switch.通过使用一种 morpholino 寡核苷酸阻断外显子 4 的 5' 剪接位点可引发 APOL1 蛋白异构体转换。
Sci Rep. 2018 Jun 7;8(1):8739. doi: 10.1038/s41598-018-27104-x.
2
Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1.外显子4编码序列是载脂蛋白L1细胞毒性的主要决定因素。
Am J Physiol Cell Physiol. 2015 Jul 1;309(1):C22-37. doi: 10.1152/ajpcell.00384.2014. Epub 2015 Apr 29.
3
Mechanistic control of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP A1, and hnRNP M.hnRNP L、hnRNP A1 和 hnRNP M 对癌胚抗原相关细胞黏附分子-1(CEACAM1)剪接异构体的机制调控
J Biol Chem. 2011 May 6;286(18):16039-51. doi: 10.1074/jbc.M110.204057. Epub 2011 Mar 11.
4
RNA sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes.对表达人类 APOL1 G2 风险变异体的分离细胞群体进行 RNA 测序,揭示了斑马鱼足细胞中镰状细胞肾病的分子相关性。
PLoS One. 2019 Jun 3;14(6):e0217042. doi: 10.1371/journal.pone.0217042. eCollection 2019.
5
hnRNP A1 Regulates Alternative Splicing of Tau Exon 10 by Targeting 3' Splice Sites.hnRNP A1 通过靶向 3' 剪接位点调节 Tau 外显子 10 的可变剪接。
Cells. 2020 Apr 10;9(4):936. doi: 10.3390/cells9040936.
6
Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity.招募载脂蛋白 L1 肾病风险变异体到脂滴可减轻细胞毒性。
Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3712-3721. doi: 10.1073/pnas.1820414116. Epub 2019 Feb 7.
7
hnRNP A1 and secondary structure coordinate alternative splicing of Mag.hnRNP A1 和二级结构协调 Mag 的可变剪接。
RNA. 2013 Jul;19(7):948-57. doi: 10.1261/rna.036780.112. Epub 2013 May 23.
8
Apolipoprotein L1 (APOL1) cation current in HEK-293 cells and in human podocytes.载脂蛋白 L1 (APOL1) 在 HEK-293 细胞和人足细胞中的阳离子电流。
Pflugers Arch. 2023 Mar;475(3):323-341. doi: 10.1007/s00424-022-02767-8. Epub 2022 Nov 30.
9
Control of hnRNP A1 alternative splicing: an intron element represses use of the common 3' splice site.异质核糖核蛋白A1可变剪接的调控:一个内含子元件抑制常见3'剪接位点的使用。
Mol Cell Biol. 2000 Oct;20(19):7353-62. doi: 10.1128/MCB.20.19.7353-7362.2000.
10
Global identification of hnRNP A1 binding sites for SSO-based splicing modulation.基于单链寡核苷酸的剪接调控中hnRNP A1结合位点的全基因组鉴定。
BMC Biol. 2016 Jul 5;14:54. doi: 10.1186/s12915-016-0279-9.

引用本文的文献

1
Apolipoprotein L1 (APOL1): Consideration of Molecular Evolution, Interaction with APOL3, and Impact of Splice Isoforms Advances Understanding of Cellular and Molecular Mechanisms of Cell Injury.载脂蛋白L1(APOL1):对分子进化、与APOL3相互作用以及剪接异构体影响的思考推动了对细胞损伤的细胞和分子机制的理解。
Cells. 2025 Jul 2;14(13):1011. doi: 10.3390/cells14131011.
2
A Cell Biologist's View on APOL1: What We Know and What We Still Need to Address.一位细胞生物学家对载脂蛋白L1(APOL1)的看法:我们所知道的以及仍需解决的问题。
Cells. 2025 Jun 24;14(13):960. doi: 10.3390/cells14130960.
3
Apolipoprotein L1 is a tumor suppressor in clear cell renal cell carcinoma metastasis.

本文引用的文献

1
Intracellular APOL1 Risk Variants Cause Cytotoxicity Accompanied by Energy Depletion.细胞内载脂蛋白L1(APOL1)风险变异体导致细胞毒性并伴有能量耗竭。
J Am Soc Nephrol. 2017 Nov;28(11):3227-3238. doi: 10.1681/ASN.2016111220. Epub 2017 Jul 10.
2
A tripartite complex of suPAR, APOL1 risk variants and αβ integrin on podocytes mediates chronic kidney disease.足细胞上的suPAR、APOL1风险变异体和αβ整合素三方复合物介导慢性肾脏病。
Nat Med. 2017 Aug;23(8):945-953. doi: 10.1038/nm.4362. Epub 2017 Jun 26.
3
Using Morpholinos to Control Gene Expression.
载脂蛋白L1是透明细胞肾细胞癌转移中的一种肿瘤抑制因子。
Front Oncol. 2024 Apr 12;14:1371934. doi: 10.3389/fonc.2024.1371934. eCollection 2024.
4
IFI16 Is Indispensable for Promoting HIF-1α-Mediated APOL1 Expression in Human Podocytes under Hypoxic Conditions.IFI16 对于促进低氧条件下人足细胞中 HIF-1α 介导的 APOL1 表达是必不可少的。
Int J Mol Sci. 2024 Mar 15;25(6):3324. doi: 10.3390/ijms25063324.
5
APOL1 nephropathy - a population genetics success story.APOL1 肾病——一个群体遗传学的成功案例。
Curr Opin Nephrol Hypertens. 2024 Jul 1;33(4):447-455. doi: 10.1097/MNH.0000000000000977. Epub 2024 Feb 28.
6
Apolipoprotein L1 (APOL1) renal risk variant-mediated podocyte cytotoxicity depends on African haplotype and surface expression.载脂蛋白 L1 (APOL1) 肾脏风险变异介导的足细胞细胞毒性取决于非洲单倍型和表面表达。
Sci Rep. 2024 Feb 14;14(1):3765. doi: 10.1038/s41598-024-53298-4.
7
hnRNP A1 in RNA metabolism regulation and as a potential therapeutic target.异质性核糖核蛋白A1在RNA代谢调控中及作为潜在治疗靶点的作用
Front Pharmacol. 2022 Oct 21;13:986409. doi: 10.3389/fphar.2022.986409. eCollection 2022.
8
Endoplasmic reticulum-translocation is essential for APOL1 cellular toxicity.内质网转位对于载脂蛋白L1(APOL1)的细胞毒性至关重要。
iScience. 2021 Dec 31;25(1):103717. doi: 10.1016/j.isci.2021.103717. eCollection 2022 Jan 21.
9
Lack of APOL1 in proximal tubules of normal human kidneys and proteinuric APOL1 transgenic mouse kidneys.正常人类肾脏近端小管中缺乏 APOL1 及蛋白尿相关的 APOL1 转基因小鼠肾脏中缺乏 APOL1。
PLoS One. 2021 Jun 17;16(6):e0253197. doi: 10.1371/journal.pone.0253197. eCollection 2021.
10
Apolipoprotein L1 and mechanisms of kidney disease susceptibility.载脂蛋白 L1 与肾病易感性的机制。
Curr Opin Nephrol Hypertens. 2021 May 1;30(3):317-323. doi: 10.1097/MNH.0000000000000704.
使用吗啉代寡核苷酸来控制基因表达。
Curr Protoc Nucleic Acid Chem. 2017 Mar 2;68(1):4.30.1-4.30.29. doi: 10.1002/cpnc.21.
4
Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.足细胞中人类APOL1风险变异体的转基因表达可诱发小鼠肾病。
Nat Med. 2017 Apr;23(4):429-438. doi: 10.1038/nm.4287. Epub 2017 Feb 20.
5
Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease.骨髓来源的未成熟髓样细胞是循环suPAR的主要来源,其导致蛋白尿性肾病。
Nat Med. 2017 Jan;23(1):100-106. doi: 10.1038/nm.4242. Epub 2016 Dec 12.
6
APOL1-Mediated Cell Injury Involves Disruption of Conserved Trafficking Processes.APOL1介导的细胞损伤涉及保守运输过程的破坏。
J Am Soc Nephrol. 2017 Apr;28(4):1117-1130. doi: 10.1681/ASN.2016050546. Epub 2016 Nov 18.
7
Renal-Risk Variants Induce Mitochondrial Dysfunction.肾脏风险变异体导致线粒体功能障碍。
J Am Soc Nephrol. 2017 Apr;28(4):1093-1105. doi: 10.1681/ASN.2016050567. Epub 2016 Nov 7.
8
Characterization of the Regulation of CD46 RNA Alternative Splicing.CD46 RNA可变剪接调控的表征
J Biol Chem. 2016 Jul 1;291(27):14311-14323. doi: 10.1074/jbc.M115.710350. Epub 2016 May 12.
9
APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.APOL1肾病风险变异体通过消耗细胞内钾离子和诱导应激激活蛋白激酶而导致细胞毒性。
Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):830-7. doi: 10.1073/pnas.1522913113. Epub 2015 Dec 23.
10
Role of an SNP in Alternative Splicing of Bovine NCF4 and Mastitis Susceptibility.一个单核苷酸多态性在牛NCF4可变剪接及乳腺炎易感性中的作用
PLoS One. 2015 Nov 24;10(11):e0143705. doi: 10.1371/journal.pone.0143705. eCollection 2015.